Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Multiple Myeloma, Plasma Cell Biology

Kenneth Anderson

MD

🏢Dana-Farber Cancer Institute, Harvard Medical School🌐USA

Kraft Family Professor of Medicine

120
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Kenneth Anderson is a world-renowned multiple myeloma specialist who discovered the activity of thalidomide and bortezomib in myeloma, transforming the treatment landscape. He has spent decades investigating the bone marrow microenvironment and how it supports myeloma cell survival and drug resistance. His laboratory at Dana-Farber developed novel therapeutic strategies targeting myeloma-stromal cell interactions. He continues to lead international myeloma clinical trials and translational research programs.

Share:

🧪Research Fields 研究领域

multiple myeloma
bortezomib
proteasome inhibitor
bone marrow microenvironment
myeloma immunotherapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Kenneth Anderson 的研究动态

Follow Kenneth Anderson's research updates

留下邮箱,当我们发布与 Kenneth Anderson(Dana-Farber Cancer Institute, Harvard Medical School)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment